Tianeptine, a atypical antidepressant, works through a novel mechanism compared to standard antidepressants, primarily impacting the regulation of serotonin pathways . Initially developed in the European Union, it’s increasingly utilized off-label to treat major depressive disorder , particularly when alternative treatments seem unsuccessful. How